OXUR.BR
Price:
$0.96
Market Cap:
$1.41M
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV ...[Read more]
Industry
Biotechnology
IPO Date
2006-07-07
Stock Exchange
EURONEXT
Ticker
OXUR.BR
According to Oxurion NV’s latest financial reports and current stock price. The company's current Enterprise Value is 12.12M. This represents a change of -99.98% compared to the average of 50.48B of the last 4 quarters.
The mean historical Enterprise Value of Oxurion NV over the last ten years is 1.00T. The current 12.12M Enterprise Value has changed -99.88% with respect to the historical average. Over the past ten years (40 quarters), OXUR.BR's Enterprise Value was at its highest in in the December 2012 quarter at 16.20T. The Enterprise Value was at its lowest in in the September 2008 quarter at 0.
Average
1.00T
Median
1.05T
Minimum
9.92B
Maximum
2.36T
Discovering the peaks and valleys of Oxurion NV Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 34.44%
Maximum Annual Enterprise Value = 2.36T
Minimum Annual Increase = -97.68%
Minimum Annual Enterprise Value = 9.92B
Year | Enterprise Value | Change |
---|---|---|
2023 | 9.92B | -38.59% |
2022 | 16.16B | -97.68% |
2021 | 697.54B | -28.70% |
2020 | 978.34B | -13.39% |
2019 | 1.13T | -18.08% |
2018 | 1.38T | 12.37% |
2017 | 1.23T | 34.44% |
2016 | 912.77B | -29.72% |
2015 | 1.30T | -45.00% |
2014 | 2.36T | -68.49% |
The current Enterprise Value of Oxurion NV (OXUR.BR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
241.21B
5-year avg
566.31B
10-year avg
1.00T
Oxurion NV’s Enterprise Value is less than Biocartis Group NV (154.30M), less than Mithra Pharmaceuticals SA (211.81M), less than MDxHealth SA (102.97M), less than Celyad Oncology SA (20.50M), less than argenx SE (30.93B),
Company | Enterprise Value | Market cap |
---|---|---|
154.30M | $27.24M | |
211.81M | $14.93M | |
102.97M | $85.63M | |
20.50M | $9.82M | |
30.93B | $29.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxurion NV using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oxurion NV or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oxurion NV's Enterprise Value?
What is the highest Enterprise Value for Oxurion NV (OXUR.BR)?
What is the 3-year average Enterprise Value for Oxurion NV (OXUR.BR)?
What is the 5-year average Enterprise Value for Oxurion NV (OXUR.BR)?
How does the current Enterprise Value for Oxurion NV (OXUR.BR) compare to its historical average?